These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery. Kim B; Park JH; Sailor MJ Adv Mater; 2019 Dec; 31(49):e1903637. PubMed ID: 31566258 [TBL] [Abstract][Full Text] [Related]
4. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship. Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101 [TBL] [Abstract][Full Text] [Related]
5. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Kievit FM; Zhang M Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865 [TBL] [Abstract][Full Text] [Related]
6. Oligonucleotide-based theranostic nanoparticles in cancer therapy. Shahbazi R; Ozpolat B; Ulubayram K Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380 [TBL] [Abstract][Full Text] [Related]
7. A review of small molecules and drug delivery applications using gold and iron nanoparticles. Jahangirian H; Kalantari K; Izadiyan Z; Rafiee-Moghaddam R; Shameli K; Webster TJ Int J Nanomedicine; 2019; 14():1633-1657. PubMed ID: 30880970 [TBL] [Abstract][Full Text] [Related]
8. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine. Du JZ; Li HJ; Wang J Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728 [TBL] [Abstract][Full Text] [Related]
9. Gold Nanoparticles as Targeted Delivery Systems and Theranostic Agents in Cancer Therapy. Mioc A; Mioc M; Ghiulai R; Voicu M; Racoviceanu R; Trandafirescu C; Dehelean C; Coricovac D; Soica C Curr Med Chem; 2019; 26(35):6493-6513. PubMed ID: 31057102 [TBL] [Abstract][Full Text] [Related]
10. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells. Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325 [TBL] [Abstract][Full Text] [Related]
11. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic. Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391 [TBL] [Abstract][Full Text] [Related]
12. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells. Yi Y; Kim HJ; Zheng M; Mi P; Naito M; Kim BS; Min HS; Hayashi K; Perche F; Toh K; Liu X; Mochida Y; Kinoh H; Cabral H; Miyata K; Kataoka K J Control Release; 2019 Feb; 295():268-277. PubMed ID: 30639386 [TBL] [Abstract][Full Text] [Related]
13. Design of Raman tag-bridged core-shell Au@Cu He J; Dong J; Hu Y; Li G; Hu Y Nanoscale; 2019 Mar; 11(13):6089-6100. PubMed ID: 30869726 [TBL] [Abstract][Full Text] [Related]
14. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging. Elzoghby AO; Hemasa AL; Freag MS J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493 [TBL] [Abstract][Full Text] [Related]
15. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics? Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009 [TBL] [Abstract][Full Text] [Related]
17. Theranostics Based on Iron Oxide and Gold Nanoparticles for Imaging- Guided Photothermal and Photodynamic Therapy of Cancer. Rajkumar S; Prabaharan M Curr Top Med Chem; 2017; 17(16):1858-1871. PubMed ID: 27875977 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles. Gautier J; Allard-Vannier E; Munnier E; Soucé M; Chourpa I J Control Release; 2013 Jul; 169(1-2):48-61. PubMed ID: 23567046 [TBL] [Abstract][Full Text] [Related]
19. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances. Gandhi NS; Tekade RK; Chougule MB J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288 [TBL] [Abstract][Full Text] [Related]
20. Advances in Gold Nanoparticles: Synthesis, Functionalization Strategies, and Theranostic Applications in Cancer. Damani M; Jadhav M; Joshi R; Singh BP; Momin MM; Ningthoujam RS; Khan T Crit Rev Ther Drug Carrier Syst; 2024; 41(6):1-56. PubMed ID: 38804553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]